Balloon dilatation of critically obstructed modified (polytetrafluoroethylene) Blalock-Taussig shunts.
Marasini
M
M
Department of Pediatric Cardiology and Cardiovascular Surgery, Giannina Gaslini Children's Hospital-Genova, Italy.
Dalmonte
P
P
Pongiglione
G
G
Dolcini
G
G
Bosoni
M
M
Ribaldone
D
D
Caponnetto
S
S
D000714:Anastomosis, Surgical / Q000009:adverse effects; D001794:Blood Pressure / Q000502:physiology; D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D002404:Catheterization / Q000379:methods; D002675:Child, Preschool; D003131:Combined Modality Therapy; D006083:Graft Occlusion, Vascular / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010100:Oxygen / Q000097:blood; D011138:Polytetrafluoroethylene; D011651:Pulmonary Artery / Q000503:physiopathology / Q000601:surgery*; D013348:Subclavian Artery / Q000601:surgery*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D011138:Polytetrafluoroethylene; D006493:Heparin; D014568:Urokinase-Type Plasminogen Activator; D010100:Oxygen